Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech World Maldives.
Press releases published on September 30, 2025
Redodo October Prime Day Early Sale: Up to 55% Off LiFePO4 Batteries
SHENZHEN, China, Sept. 30, 2025 (GLOBE NEWSWIRE) -- With this year’s Prime Big Deal Days just around the corner, Redodo’s October Prime Day Early Sale is here to help you power up your outdoor adventures, solar setups, or golf carts for less. From …
Viomi Technology Co., Ltd Filed 2024 Annual Report on Form 20-F
GUANGZHOU, China, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd (“Viomi” or the "Company") (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced that the Company has filed its annual report on Form …
Reunion Neuroscience Announces First Patient Dosed in REKINDLE Phase 2 Clinical Trial of RE104 for the Treatment of Adjustment Disorder (AjD) in Cancer and Other Medical Illnesses
-- AjD Represents an Area of Significant Unmet Need; No U.S. Food and Drug Administration (FDA)-Approved Therapies Available -- -- Following Positive Topline Data in RECONNECT Phase 2 Trial, Expect to Initiate Phase 3 Trial of RE104 in Postpartum …
From Reservation to Innovation: Hopi Day School Expands STEM Access with zSpace Imagine AR/VR Laptops
SAN JOSE, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC), a leader in immersive augmented reality (AR) solutions for education, today announced that Hopi Day School in Arizona is bringing the zSpace Imagine AR/VR laptop into …
Humanoid Global Welcomes Olivier Vincent to its Investment Advisory Board
Vancouver, BC, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering …
Rail Vision Signs Term Sheet to Acquire 51% Stake in Quantum Computing AI Company for the Transportation Industry
Ra’anana, Israel, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today announced …
Draganfly Selected by U.S. Army to Supply Flex FPV Drone Systems
Tampa, Florida, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an industry-leading developer of drone solutions and systems, today announced its selection by the U.S. Army to provide …
Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock
BEDFORD, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (Nasdaq: OCUL) (“Ocular”, the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced the pricing of an underwritten …
Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto
Carlsbad, CA, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or “the Company”) today announced the successful closing of a $41 million private investment in public equity (PIPE) financing led by Faraday Future …
Louisiana State University Accelerates Research with ManageX Self-Service Cloud Platform
BELLEVUE Wash., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Louisiana State University (LSU) has deployed ManageX Research, a self-service cloud platform from Terawe, to empower its researchers with instant access to advanced cloud infrastructure and AI services. …
Kynexis Announces First Patient Dosed in Phase 2 Clinical Trial of KYN-5356 for Cognitive Impairment Associated With Schizophrenia
Based on previously reported positive Phase 1 results, Kynexis is advancing KYN-5356, a first-in-class KAT-II inhibitor, into a Phase 2 clinical trial in patients with cognitive impairment associated with schizophrenia Phase 2 trial seeks to establish …
Opus Genetics Reports Positive Pediatric Data from OPGx-LCA5 Phase 1/2 Trial in Leber Congenital Amaurosis Type 5 (LCA5)
Pediatric participants demonstrated large gains in cone-mediated vision; therapy remains well tolerated with no ocular serious adverse events or dose-limiting toxicities Lasting, durable responses observed out to 18 months in adult participants Expected …
Gogo Plane Simple Ka-band terminal certified for Dassault Falcon 7X and 8X aircraft
Broomfield, CO., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Gogo (NASDAQ: GOGO) announced today that the Gogo Plane Simple Ka-band tail mount antenna system has received European Union Aviation Safety Agency (EASA) supplemental type certification (STC) approvals …
Lantronix Launches EdgeFabric.ai Visual Orchestration Platform to Accelerate Edge AI Deployment
IRVINE, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today unveiled EdgeFabric.ai™, a no-code development platform purpose-built …
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025
WAYNE, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that the Company will host …
Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings
NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare …
Wrap Technologies, Inc. Plans to Hold a Conference Call to Discuss Third Quarter 2025 Financial Results on Wednesday, November 12, 2025, at 4:30 p.m. ET
MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in innovative public safety technologies and non-lethal tools, today announced it plans to hold a conference call on Wednesday, …
LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025
Additional time enables LAVA Therapeutics to address potential liabilities and confirm net cash to be delivered to Shareholders. LAVA Therapeutics and XOMA Royalty anticipate closing the announced acquisition in the fourth quarter of 2025. UTRECHT, The …
Merakris Therapeutics Secures FDA Agreement for Type C Meeting to Advance MTX-001 Development Pathway
RESEARCH TRIANGLE PARK, N.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics, a regenerative medicine company developing biologic drug therapies for hard-to-heal wounds, today announced that it is scheduled for a Type C meeting with the U.S. Food …
dog-walker.io Completes First Funding Round, Raises $500,000, and Sets Timeline for App Launch and Token Listing
LONDON, Sept. 30, 2025 (GLOBE NEWSWIRE) -- dog-walker.io, a blockchain-powered platform designed to connect dog owners with professional walkers, has successfully closed its first funding round. The company secured over $500,000 USD, marking a major …